Cathy Eng/X
Oct 17, 2024, 18:42
Cathy Eng: We have now completed 3 phase III clinical trials in a ‘rare cancer’ with EA2176 and EA2182
Cathy Eng, Co-Director of GI Oncology at the Vanderbilt-Ingram Cancer Center, shared a post on X:
”Great month for NCI CTEP Clinical Research and ECOG-ACRIN Cancer Research Group. We have now completed 3 phase III clinical trials in a ‘rare cancer’ with EA2176 and EA2182! Also our pending results of EA2165! Thank you to all providers and patients for your support!”
Source: Cathy Eng/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 18, 2024, 03:36
Dec 18, 2024, 02:49
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36